General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Klug C et al. – Median surveillance period was 101.4 months. 5–year overall survival probability was 53.9%. 5–year local control probability was 70.2%. The results underline the reliability of preoperative treatment of patients with oral and oropharyngeal cancer.

Related Articles

Radiochemotherapy in the elderly with lung cancer
Expert Review of Anticancer Therapy, 10/22/09    Relevance Score: 82%

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
Journal of Clinical Oncology, 11/12/09    Relevance Score: 80%

A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer
Annals of Surgical Oncology, 10/28/09    Relevance Score: 80%

Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09    Relevance Score: 77%

Combination of radiotherapy and chemotherapy in locally advanced NSCLC
Expert Review of Anticancer Therapy, 10/20/09    Relevance Score: 77%

Today in Oral Cavity...keeping you current

Microbiology of third and fourth branchial pouch cysts
The Laryngoscope, 12/16/09

Comparative analysis of slot dimension in lingual bracket systems
Head & Face Medicine, 12/16/09

Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer
The Laryngoscope, 12/11/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address